Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Other Operating Expenses (2020 - 2025)

INVO Fertility has reported Other Operating Expenses over the past 6 years, most recently at $1.2 million for Q3 2025.

  • Quarterly Other Operating Expenses changed N/A to $1.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Sep 2025, up 422.29% year-over-year, with the annual reading at $94551.0 for FY2024, 100.84% up from the prior year.
  • Other Operating Expenses was $1.2 million for Q3 2025 at INVO Fertility, down from $2.5 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $15.9 million in Q1 2025 and troughed at -$6.2 million in Q4 2023.
  • The 5-year median for Other Operating Expenses is $46060.0 (2021), against an average of $716104.8.
  • Year-over-year, Other Operating Expenses plummeted 84525.46% in 2022 and then soared 16710.37% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at -$11432.0 in 2021, then surged by 3276.89% to $363182.0 in 2022, then plummeted by 1802.99% to -$6.2 million in 2023, then soared by 101.53% to $94551.0 in 2024, then surged by 1204.16% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Other Operating Expenses are $1.2 million (Q3 2025), $2.5 million (Q2 2025), and $15.9 million (Q1 2025).